Connect Biopharma Holdings Ltd. (CNTB)
0.6652
+0.09
(+14.93%)
USD |
NASDAQ |
Nov 18, 16:00
0.6548
-0.01
(-1.56%)
After-Hours: 20:00
Connect Biopharma Holdings EPS Diluted (Quarterly) : -0.2749 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2749 |
| March 31, 2026 | -0.343 |
| December 31, 2025 | -0.2695 |
| Date | Value |
|---|---|
| September 30, 2025 | -0.3087 |
| June 30, 2025 | -0.2324 |
| March 31, 2025 | -0.1856 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | 0.0842 |
| Vaxcyte, Inc. | -1.995 |
| Foghorn Therapeutics, Inc. | 0.8011 |
| Caribou Biosciences, Inc. | -0.2475 |
| Oncolytics Biotech, Inc. | -0.0759 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.28M |
| Revenue (Quarterly) | 2.768M |
| Total Expenses (Quarterly) | 20.05M |
| Enterprise Value | 11.00M |
| Profit Margin (Quarterly) | -624.4% |
| Earnings Yield | -179.8% |
| Normalized Earnings Yield | -179.81 |